Dare Bioscience Files Q1 2025 10-Q
Ticker: DARE · Form: 10-Q · Filed: May 13, 2025 · CIK: 1401914
Sentiment: neutral
Topics: 10-Q, pharmaceuticals, financials
TL;DR
Dare Bioscience Q1 2025 10-Q filed. Financials updated.
AI Summary
Dare Bioscience, Inc. filed its quarterly report for the period ending March 31, 2025. The company, formerly known as Cerulean Pharma Inc. and Tempo Pharmaceuticals Inc., is based in San Diego, CA. The filing details financial information and business operations for the first quarter of 2025.
Why It Matters
This filing provides investors with an update on Dare Bioscience's financial health and operational progress during the first quarter of 2025, crucial for understanding the company's trajectory.
Risk Assessment
Risk Level: medium — As a pharmaceutical company, Dare Bioscience faces inherent risks related to drug development, regulatory approvals, and market competition.
Key Numbers
- 2025-03-31 — Reporting Period End Date (Indicates the end of the financial quarter being reported.)
- 2025-05-13 — Filing Date (The date the 10-Q was officially submitted to the SEC.)
Key Players & Entities
- Dare Bioscience, Inc. (company) — Filer of the 10-Q
- Cerulean Pharma Inc. (company) — Former name of Dare Bioscience
- Tempo Pharmaceuticals Inc (company) — Former name of Dare Bioscience
- 20250331 (date) — End of the reporting period
- 20250513 (date) — Filing date
FAQ
What is the primary business of Dare Bioscience, Inc.?
Dare Bioscience, Inc. operates in the Pharmaceutical Preparations industry (SIC code 2834).
When was the reporting period for this 10-Q filing?
The conformed period of report was March 31, 2025.
What were Dare Bioscience's former company names?
Dare Bioscience, Inc. was formerly known as Cerulean Pharma Inc. and Tempo Pharmaceuticals Inc.
What is the business address of Dare Bioscience?
The business address is 3655 NOBEL DRIVE, SUITE 260, SAN DIEGO, CA 92122.
What is the SEC file number for Dare Bioscience?
The SEC file number is 001-36395.
Filing Details
This Form 10-Q (Form 10-Q) was filed with the SEC on May 13, 2025 regarding Dare Bioscience, Inc. (DARE).